Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2003
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104380 Compositions and methods for labeling oligonucleotides
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467870A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/04/2003EP1315732A2 Radicicol and monocillin and their analogues and uses thereof
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315700A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1165565B1 Optically pure camptothecin analogues
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
06/04/2003EP0805157B1 Indole derivatives and medicinal use thereof
06/04/2003EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
06/04/2003CN1422274A Alkylated imidazopyridine derivatives
06/04/2003CN1110499C Spiro-quinuclidine derivatives, their preparation and use
06/04/2003CN1110485C 1-arylsulphonyl, aryl (thio) Carbonyl pyridazino derivatives and producing process thereof
06/03/2003US6573380 Useful in photochemical polymerization, dye lasers, and electroluminescent elements
06/03/2003US6573376 Solvent extraction; plant extracts
06/03/2003US6573292 Treatment of Chronic Lymphocytic Leukemia and B- cell and T-cell lymphomas are provided. These methods comprise administering to a patient in need of treatment an effective amount of certain indole and carbazole compounds, such as
06/03/2003US6573283 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
06/03/2003US6573277 Metalloproteinase inhibitor
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
05/2003
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003043584A2 Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2002085848A8 Synthesis of pancratistatin prodrugs
05/29/2003US20030100578 For example, (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7H-8,9 -dihydro-pyrano-(2,3-c)imidazo(1,2-a)pyridine
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100560 Such as 2,3-dimethoxy-dibenzo(c,h)cinnoline for treatment of cancer; fungicides
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030099910 For use in photo switches, photochromic filters, light stabilizers, paper money or cards for preventing counterfeit forgeries, display elements, optical recording media or photo integrated elements
05/29/2003US20030099807 Optical recording medium
05/28/2003EP1313740A1 Prodrugs of imidazopyridine derivatives
05/28/2003EP1313739A1 Alkylated imidazopyridine derivatives
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003CN1420890A Tricyclic imidazopyridines
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420114A 2,3-disubstd. -4(3H)-quinazolones
05/28/2003CN1109686C Acronycine compounds and pharmaceutical compositions contg. them
05/27/2003US6569892 Useful as agent for measurement of nitrogen monoxide, also for measuring intracellular nitrogen monoxide concentration of an individual
05/27/2003US6569881 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
05/27/2003US6569870 Fluorinated quinolones as antimitotic and antitumor agents
05/27/2003US6569865 Psychological disorders; Alzheimer's disease
05/27/2003US6569859 Synthetic analogs of ecteinascidin-743
05/27/2003US6569858 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
05/27/2003US6569848 Compounds for the treatment of alzheimer's disease
05/27/2003US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms
05/22/2003WO2003042210A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/22/2003WO2003042203A1 Chromene compound
05/22/2003WO2003041660A2 Solubilized topoisomerase poisons
05/22/2003WO2003041653A2 Cytotoxic agents
05/22/2003US20030096852 Inhibiting binding interaction between hGH (human growth hormone) or a mutant thereof and an hGH binding protein or receptor in mammal administering benzimidazole compound
05/22/2003US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096813 Compositions useful as inhibitors of GSK-3
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096381 Production of polyketides
05/22/2003US20030096192 For application to polycarbonate substrate by spin coating or vapor deposition
05/22/2003US20030096117 Base structure is a chromene(3,2-a)fluorene ring containing spiro-fused rings; photochromic lenses; large fading rate, less color when deteriorated, and excellent light resistance in the photochromic properties
05/22/2003CA2466344A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/21/2003EP1311487A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/21/2003EP1311300A1 Radioligand and binding assay
05/21/2003EP1192161B1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP0964863B1 Oxazolidines as 5-ht2a-antagonists
05/21/2003EP0923581B1 4-substituted beta-carbolines as immunomodulators
05/21/2003CN1419558A Process for producing camptothecin
05/21/2003CN1419557A Novel process for producing fused imidazopridine derivative and novel crystal form
05/21/2003CN1419556A Pyrano [2,3-C] imidazo[-1,2-A] pyridine convenant au traitement de troubles gastrointestinal disorders
05/21/2003CN1419555A Ketol fatty acid derivatives and plant growth regulating agents
05/21/2003CN1109033C 8-subtituted-9H-1,3-dioxolo/4,5-h/2, 2/henzodiazepine derivatives, as Ampa/kainate receptor inhibitors
05/20/2003US6566553 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline
05/20/2003US6566533 Reacting aza-heterocyclic compounds (indoles and carbazoles) with alkyl- or aryl-halides in the presence of carbon dioxide and alkali carbonate
05/20/2003US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/20/2003US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
05/20/2003US6566364 Linear or cyclic ureas
05/20/2003US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors
05/20/2003US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/20/2003US6566071 Useful as fluorescent labeling reagents
05/15/2003WO2003040129A1 Halogenated nitrobutadienes for controlling animal pests
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003WO2003039258A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
05/15/2003WO2003031435A8 Pyrazole derivatives as glycine transporter inhibitors
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 298